Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Autoimmune Diseases
 More »

  • RuiYi Licenses mAb Development to China's Genor
    RuiYi is eager to launch RYI-008 in the world's most populous nation as a treatment for cancer and autoimmune diseases-especially rheumatoid arthritis, which affects some 4.1 ...
    5-16-2013
  • Seasoned Drugs Offer Therapeutic Gold Mine
    ... It can also analyze the relevance of all drugs against diseases of interest. "COSS ... dysfunction in MS, which previously had been thought a purely autoimmune disease. ...
    5-15-2013
  • Biomarkers Take Center Stage
    ... Cytokines have become attractive biomarkers and candidates for targeted therapies for a number of autoimmune diseases, including rheumatoid arthritis (RA), Crohn's disease, and ...
    5-1-2013
  • Ligand Buys Potential Milestone/Royalty Portfolio in Up To $4...
    The deal also expands Ligand's presence in growing therapeutic markets such as oncology, inflammation, and autoimmune diseases. "The acquired rights are a great fit with our ...
    4-30-2013
  • EpiVax and BioAtla Merge Screening Technologies
    In February, EpiVax collaborated with Novozymes Biopharma in a research agreement for the development of new methods for treating autoimmune diseases. The research agreement ...
    4-24-2013
  • Poland Invests in Biotech Infrastructure
    At this center, scientists are developing biosimilar antibodies to treat autoimmune diseases, as well as cancers and other disorders. Piotr Zien, Ph.D., head of science projects at ...
    4-15-2013
  • Thermo Fisher's (Mostly) Buying Spree
    acquired the developer of blood tests for the clinical diagnosis and monitoring of allergies and autoimmune diseases. Phadia becomes part of Thermo's Specialty Diagnostics segment. ...
    4-15-2013
  • Yale Wins $10 Million Grant for Novel Immunobiology Research
    chronic illnesses, including cardiovascular disease, type 2 diabetes, autoimmune diseases, asthma and allergies, neurodegenerative diseases such as Alzheimer's disease, and cancer. ...
    4-9-2013
  • KannaLife in R&D Collaboration for Cannabinoid-Based Drugs
    receptor antagonism, making them useful in treating and protecting the body from a variety of oxidation-associated ischemic, age-related, inflammatory, and autoimmune diseases. ...
    4-4-2013
  • Medicine: Getting Personal
    cure intractable and disabling diseases than the emerging fields of cell and gene therapy. ... antigens without provoking an autoimmune reaction, thereby sparing the healthy tissue. ...
    3-15-2013
  • PhRMA Report: 907 Drugs, Vaccines in Development
    As with the earlier report, some of the drug candidates cited by PhRMA this year were listed in more than one disease category. Another 71 medicines were for autoimmune diseases ...
    3-14-2013
  • Takeda Expands Envoy-Scripps Collaboration
    Scripps to develop new drugs: in February, they announced a partnership with Resolve Therapeutics to develop compounds for the treatment of lupus and other autoimmune diseases. ...
    3-13-2013
  • Sorrento Boosts Cancer Pipeline with Igdrasol Purchase
    ... and preclinical antibody programs, including those targeting metabolic, autoimmune, and infectious diseases, together with Igdrasol's expertise in drug formulation and drug ...
    3-7-2013
  • Single Gene Mutation May Cause Type 1 Diabetes
    A single gene, SIRT1, may be involved in the development of type 1 diabetes (T1D) and other autoimmune diseases, according to researchers at University Hospital Basel in ...
    3-6-2013
  • Small Firms Look Optimistically to Future
    The company is interested in collaborative options for high-value targets that will help sustain growth. VX-509 for autoimmune diseases, for example, may be a platform for multiple ...
    3-1-2013
  • More »

    Journal Articles

  • The Survey on Cellular and Engineered Tissue Therapies in Europe...
    Chiara Bocelli-Tyndall, Ineke Slaper-Cortenbach, Jakob Passweg, Alan Tyndall, Ivan Martin, Helen Baldomero
    Tissue Engineering, Part A
    7% autologous), musculoskeletal (17%; 98% autologous), epithelial/parenchymal (8%; 73% autologous), autoimmune (9%; 84% autologous), or neurological diseases (3%; 50% autologous). ...
  • Statins Could Be Used to Control Replication of Some Viruses...
    Caroline Gilbert, Marc Bergeron, Sylvie Méthot, Jean-François Giguère, Michel J. Tremblay
    Viral Immunology
    LFA-1 affinity by inhibiting prenylation of the small GTPases could prove useful to treat inflammatory, autoimmune diseases and possibly viral infections, including HIV-1.
  • Adipose-Tissue-Derived and Wharton's Jelly-Derived Mesenchymal...
    Mehdi Najar, Gordana Raicevic, Hicham Id Boufker, Hussein Fayyad-Kazan, Cécile De Bruyn, Nathalie Meuleman, Dominique Bron, Michel Toungouz, Laurence Lagneaux
    Tissue Engineering, Part A
    and/or reduction of graft-versus-host disease and in the treatment of autoimmune diseases, is particularly promising. Further characterization of MSC physiological ...
  • Interferon Induced with Helicase C Domain 1 (IFIH1) and Virus...
    Dimitry A. Chistiakov
    Viral Immunology
    association of interferon induced with helicase C domain 1 (IFIH1) gene variants encoding a viral RNA-sensing helicase with susceptibility to several autoimmune diseases was found. ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll